GB Sciences Inc (OTCMKTS:GBLX) says it will unveil some new medical cannabis products in a matter of months. This business guru believes it is good to educate Louisiana pharmacists and physicians about the products. The company’s subsidiary GB...

GB Sciences Inc (OTCMKTS:GBLX) announced on Wednesday that its subsidiary GBS Global Biopharma, Inc. filed a patent application for its chronic pain formulations made using cannabis extracts. The newly filed patent covers the proprietary...

In the last trading session, the stock price of GB Sciences Inc (OTCMKTS:GBLX) gained more than 22% to close the day at $0.8003. Among other updates, back in the month of October, the company reported that it has finalized a production deal...